查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190571

診斷影像市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Diagnostic Imaging Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內（2022 年至 2027 年），診斷影像市場的複合年增長率將接近 6.1%。

預計 COVID-19 大流行將對市場產生重大影響。 根據 2020 年 11 月在 European Radiology 上發表的文章“入院胸片預測住院 COVID-19 患者的早期插管”，胸片有助於識別可能迅速惡化的 COVID-19 患者，以幫助告知臨床管理和醫院病床和通風分配。 這將增加該設備在醫院 COVID 病房中的使用。 2020 年 4 月，德國倫琴學會 (DRG) 發布了在 COVID-19 患者中使用 CT 掃描的指南。 根據 DRG，對於初始 PCR 和臨床結果為陰性的有臨床症狀的患者，建議對 COVID-19 進行診斷性 CT 掃描。 還建議通過順序逆轉錄 PCR (RT-PCR) 確認 CT 結果。 同樣，2020 年 4 月，英國啟動了國家 COVID-19 胸部影像數據庫 (NCCID)，該數據庫提供了對 COVID-19 的更全面了解，以及來自該國 20 個 NHS 信託機構的 X 射線、CT 和 MRI 掃描。我們正在整理數據並使用人工智能 (AI) 來檢測疾病模式和病毒標記，從而實現更準確的早期診斷和預後，並為新療法提供信息。 預計這將在 COVID-19 大流行期間增加對此類設備和測試的需求。 產品發布也是市場增長的原因之一。 例如，2020 年 11 月，皇家飛利浦為放射科醫生推出了“飛利浦高級可視化工作空間-IntelliSpace Portal 12”。 IntelliSpace Portal 現在配備了人工智能驅動的定量評估和自動結果生成功能，以支持診斷工作流程，包括心髒病學、肺病學、腫瘤學和神經病學的隨訪和交流。 其 AI 輔助肺功能還包括評估與 COVID-19相關的複雜肺部疾病。

推動診斷影像市場增長的主要因素包括慢性病患病率上升、先進醫學影像技術的採用率增加以及老年人口增加。

全球慢性病負擔日益加重，影像學診斷在慢性病的準確診斷中發揮著重要作用。 老齡化社會的到來和社會行為的改變導致這些常見且代價高昂的長期健康問題穩步增加。 許多慢性病死亡歸因於癌症、心血管疾病、肥胖症和糖尿病。 據 GLOBOCAN 稱，2020 年全球將報告約 1930 萬例新癌症病例，預計到 2040 年這一數字將增至 3020 萬例。 新興市場將受到最大影響，因為人口增長預計將在發展中地區最為明顯。

正在開發新的治療和診斷模型，以提供準確的結果，幫助及早發現疾病，並最大限度地降低治療這些疾病的成本。 隨著可支配收入的增加，人們越來越多地使用成像方式來早期發現疾病。

在數字和通信技術進步的推動下，醫學成像領域正在以非常快的速度發展。 大多數診斷實驗室和醫院都可以使用揭示解剖細節的新成像技術。 目標是提高訪問和準確性，降低成本，並使其免受輻射和有害。 趨勢是從固定設備轉向便攜式設備。 例如，直到最近，尺寸和功率要求還阻礙了超聲波的正確使用。 小型超聲系統可以完全依靠電池供電進行彩色血流多普勒成像。

診斷影像設備的市場趨勢

預計在預測期內中端 CT 掃描儀（約 64 層）將佔據最大的市場份額

由於 COVID-19 的爆發，計算機斷層掃描 (CT) 掃描儀在市場上經歷了巨大的增長。 公司已採取一些明確的步驟來滿足全球對掃描儀不斷增長的需求。 例如，2020 年 2 月，三星 NeuroLogica 在 COVID-19 病例激增的情況下加緊生產 32 層 CT 掃描儀“mobile BodyTom”。 它的內部屏蔽設計允許在護理點對 COVID-19 患者進行掃描，同時最大限度地減少接觸病毒的機會。 因此，COVID-19的出現有望提振市場。

與低端 CT 掃描儀相比，中端 CT 掃描儀更適合血管造影。 它的高速和靈敏性使醫療保健專業人員能夠查看動脈壁的斑塊形成、查看最小的血管和動脈分支，並且適用於心臟檢查。

公司不斷開發新產品以增加其在市場上的影響力。 例如，2020年1月，Arranger與佳能醫療系統公司共同推出了新型CT掃描儀“ACUTOM 32”。 該掃描儀是一款 32 層 CT 掃描儀，具有 32 厘米寬的孔門架、大約 2.0 MHU 的 X 射線管和大約 0.75 秒的旋轉時間。 同樣在 2022 年 1 月，佩裡港醫院保健中心 (PPHF) 超額完成了籌集 400 萬美元的目標，用於在 Skagog 保健中心安裝 CT 掃描儀和其他關鍵設備。

因此，預計這些 CT 掃描儀的產品發布數量將增加，從而使市場增長更加繁榮。

北美佔全球市場份額最大

北美佔診斷影像市場的主要份額，預計在預測期內將呈現類似的趨勢，不會出現重大波動。 由於 COVID-19 的爆發，預計還將觀察到對研究市場的深遠影響。 代表美國近 40,000 名放射科醫師的美國放射學會 (ACR) 表示，COVID-19 具有極強的傳染性，因此應將 CT 和 X 射線用作一線診斷和篩查工具。我們已發布指南，指出它不是。

美國在診斷影像市場佔有很大份額，據認為 2020 年 10 月，Siemens Healthmeyers 的 Ysio Max 數字放射成像系統獲得 FDA 批准，該系統具有新的檢測器和可用性功能，可改善成像和速度檢查。。

此外，由於發達的醫療機構的存在、人口老齡化對先進醫療系統的需求增加以及慢性病的增加，預計在預測期內市場將擴大。 預計腦腫瘤等神經系統疾病患病率的上升也將推動市場增長。 據美國腦腫瘤協會稱，2020 年美國將有 70 萬人患有腦腫瘤，約有 87,000 人將被診斷出患有腦腫瘤。 因此，預計上述因素將在預測期內推動同一地區的市場。

影像診斷市場競爭分析

市場是分散的，因為市場上有多家公司。 主要參與者包括 Siemen Healthineers、Koninklijke Philips NV、GE Healthcare、Hologic Corporation 和 Mindray Medical International Limited。 市場參與者專注於研發以開發技術先進的產品，以降低與產品相關的成本和副□□作用。 由於該行業的進入壁壘高，一些大公司佔據了最大的市場份額。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 慢性病增加
    • 在醫學成像領域更多地採用先進技術
    • 老年人口增加
  • 市場製約因素
    • 昂貴的程序和設備
    • 診斷成像的副作用
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按方式
    • 核磁共振
      • 低/中磁場 MRI 設備（小於 1.5T）
      • 高場 MRI 系統 (1.5-3T)
      • 超高磁場/超高磁場核磁共振設備（3T以上）
    • 計算機斷層掃描
      • 低端掃描儀（~16-Slice）
      • 中端掃描儀（約 64 片）
      • 高端掃描儀（128 層或更多）
    • 超聲診斷設備
      • 二維超聲
      • 3D 超聲
      • 其他超聲波
    • X光
      • 模擬
      • 數字
    • 核醫學成像
      • 正電子發射斷層掃描 (PET)
      • 單光子發射計算機斷層掃描 (SPECT)
    • 透視設備
    • 乳腺攝影
  • 通過使用
    • 心髒病學
    • 腫瘤科
    • 神經病學
    • 骨科
    • 胃腸病學
    • 婦科
    • 其他用途
  • 最終用戶
    • 醫院
    • 診斷中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Canon Medical Systems Corporation
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE Healthcare
    • Hologic Corporation
    • Koninklijke Philips NV
    • Shimadzu Medical
    • Siemens Healthineers
    • Mindray Medical International Limited
    • Browns Medical Imaging（BMI）
    • Samsung Electronics Co. Ltd
    • Koning Corporation

第7章 市場機會與今後動向

簡介目錄
Product Code: 57005

The Diagnostic Imaging Market is expected to register a CAGR of nearly 6.1% during the forecast period (2022-2027).

The COVID-19 pandemic is expected to have a significant impact on the market. According to an article titled, Chest radiograph at admission predicts early intubation among inpatient COVID-19 patients appearing in European Radiology in November 2020, chest radiography was useful in identifying COVID-19 patients who may rapidly deteriorate and help inform clinical management and a hospital bed and ventilation allocation. This is likely to increase the usage of these devices in COVID wards of hospitals. In April 2020, the German Rontgen Society (DRG) issued a guideline for using CT scans for COVID-19 patients. According to the DRG, for a clinically symptomatic patient, with initially negative PCR and clinical consequences, a CT scan is recommended to help diagnose COVID-19. It is also recommended to confirm the CT finding by sequential reverse transcription PCRs (RT-PCRs) tests. Similarly, in April 2020, the National COVID-19 Chest Imaging Database (NCCID) was launched in United Kingdom that provides a more comprehensive understanding of COVID-19, collating X-Rays, CT, and MRI scan data from 20 NHS trusts across the country to detect disease patterns and markers of the virus using Artificial Intelligence (AI), which, in turn, enables more accurate early diagnoses and prognoses and inform new treatments. This is expected to boost the demand for such equipment and tests during the COVID-19 pandemic. Product launches are another reason for the growth of the market. For instance, in November 2020, Royal Philips launched the Philips Advanced Visualization Workspace - IntelliSpace Portal 12 for radiologists. The IntelliSpace Portal features a robust set of new AI-assisted quantitative assessment and automatic results generation features to support the diagnostic workflow, including follow-up and communication across cardiology, pulmonology, oncology, and neurology. Its AI-assisted pulmonary capabilities include the assessment of complex lung conditions associated with COVID-19.

The major factors augmenting the growth of the diagnostic imaging market include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and a rise in the geriatric population.

The burden of chronic diseases is on the rise globally, and medical imaging procedures play a crucial role in the accurate diagnosis of chronic diseases. The increase in the aging population and changes in societal behavior are contributing to a steady increase in these common and costly long-term health problems. Most of the deaths by chronic diseases are attributable to cancer, cardiovascular diseases, obesity, and diabetes. According to GLOBOCAN, in 2020, about 19.3 million new cases of cancer were reported worldwide, and this number is expected to increase to 30.2 million in 2040. The most affected would be the emerging markets, as the population growth is anticipated to be most significant in developing areas.

New models for therapy and diagnoses are being developed, which provide precise results, help in the early detection of diseases, and help minimize the cost of treating these diseases. With the increasing disposable income, people are becoming capable enough to have access to imaging procedures for the early detection of diseases.

The medical imaging field has advanced at a great pace, stimulated by advances in digital and communication technologies. New imaging techniques that reveal greater anatomical details are available in most diagnostic labs and hospitals. The aim is to improve access and precision, decrease cost, and make the impact of radiationless harmful. The trend is shifting from fixed to portable equipment. For example, until recently, size and electricity requirements have hindered the proper use of ultrasound. Smaller ultrasound equipment can provide color-flow Doppler imaging, relying on battery power solely.

Diagnostic Imaging Market Trends

Mid-range Scanners (~64-Slice) Segment under Computed Tomography expected to Account for Largest Market Share during the Forecast Period

The computed tomography (CT) scanners experienced tremendous growth in the market studied due to the outbreak of COVID-19. Companies took several definite measures in order to keep up with the growing demand for scanners all over the world. For instance, in February 2020, with the rapidly growing COVID-19 cases, Samsung NeuroLogica ramped up the production of its 32-slice CT scanner, mobile BodyTom. It allows scanning of COVID-19 patients at the point of care due to its internal shielded design and, at the same time, minimizes exposure to the virus. Hence, owing to such instances, the market is expected to boost with the emergence of COVID-19.

Mid-range CT scanners are better for performing angiography in comparison with low-range CT scanners. Its characteristics, such as high speed and sensitivity, allow healthcare professionals to view the walls of arteries for plaque formation and to observe the tiniest of vessels and arterial branches and therefore are well suited for cardiac studies.

In order to grow their presence in the market, companies are continuously engaged in the development of new products. For instance, in January 2020, Allengers, in collaboration with Canon Medical Systems Corporation, introduced a new CT scanner in the market, ACUTOM 32, which is a 32 slice CT scanner featured with wide bore gantry of 32 cm, about 2.0MHU X-ray tube, and about 0.75 seconds of rotation time. Similarly, in January 2022, the Port Perry Hospital Foundation (PPHF) surpassed its goal of raising USD 4 million to bring a CT scanner and other essential equipment to the Scugog healthcare center.

Thus, rising product launches of these CT scanners are further expected to flourish the market growth.

North America accounted for the Largest Share in the Global Market

North America is found to hold a major share of the diagnostic imaging market and is expected to show a similar trend over the forecast period, without significant fluctuations. Due to the outbreak of COVID-19, a profound impact on the market studied is also expected to observe. The American College of Radiology (ACR), which represents nearly 40,000 radiologists in United States, issued guidance that CTs and X-rays should not be used as a first-line tool to diagnose or screen for COVID-19, as it is highly contagious.

United States contributes the major share in the diagnostic imaging market, which can be attributed to the increasing technological advances, higher affordability rates from the population, and the number of diagnostic procedures increasing on a yearly basis. In October 2020, Siemens Healthineers received clearance from the FDA for the Ysio Max digital radiography system, which includes new detectors and usability features that improve imaging and quicken exams.

Also, with the presence of well-established healthcare facilities, increasing demand for advanced healthcare systems among the aging population, and increasing prevalence of chronic diseases, the market is expected to grow in the forecast period. The growing number of neurological disorders such as brain tumors is also expected to propel market growth. As per the National Brain Tumor Society, in 2020, 700,000 people in United States are living with a brain tumor and around 87,000 as expected to be diagnosed with a brain tumor. Thus, with the aforementioned factors, the market is expected to propel in this region during the forecast period.

Diagnostic Imaging Market Competitive Analysis

The market studied is fragmented owing to the presence of several players in the market. Some of the major players in the market include Siemen Healthineers, Koninklijke Philips NV, GE Healthcare, Hologic Corporation, and Mindray Medical International Limited. The market players are focusing on R&D to develop technologically advanced products in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence few major market players hold the maximum market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition​
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Prevalence of Chronic Diseases
    • 4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
    • 4.2.3 Increase in the Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures and Equipment
    • 4.3.2 Side Effects of Diagnostic Imaging
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Modality
    • 5.1.1 MRI
      • 5.1.1.1 Low and mid field MRI Systems (less than 1.5 T)
      • 5.1.1.2 High field MRI Systems (1.5-3 T)
      • 5.1.1.3 Very High and Ultra High Field MRI Systems (3T and more)
    • 5.1.2 Computed Tomography
      • 5.1.2.1 Low-end Scanners (~16-Slice)
      • 5.1.2.2 Mid-range Scanners (~64-Slice)
      • 5.1.2.3 High-end Scanners (128-Slice and More)
    • 5.1.3 Ultrasound
      • 5.1.3.1 2D Ultrasound
      • 5.1.3.2 3D Ultrasound
      • 5.1.3.3 Other Ultrasound
    • 5.1.4 X-Ray
      • 5.1.4.1 Analog Systems
      • 5.1.4.2 Digital Systems
    • 5.1.5 Nuclear Imaging
      • 5.1.5.1 Positron Emission Tomography (PET)
      • 5.1.5.2 Single Photon Emission Computed Tomography (SPECT)
    • 5.1.6 Fluoroscopy
    • 5.1.7 Mammography
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Oncology
    • 5.2.3 Neurology
    • 5.2.4 Orthopedics
    • 5.2.5 Gastroenterology
    • 5.2.6 Gynecology
    • 5.2.7 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 Esaote SpA
    • 6.1.3 FUJIFILM Holdings Corporation
    • 6.1.4 GE Healthcare
    • 6.1.5 Hologic Corporation
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Shimadzu Medical
    • 6.1.8 Siemens Healthineers
    • 6.1.9 Mindray Medical International Limited
    • 6.1.10 Browns Medical Imaging (BMI)
    • 6.1.11 Samsung Electronics Co. Ltd
    • 6.1.12 Koning Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS